These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma. Sangro B, Bilbao JI, Boan J, Martinez-Cuesta A, Benito A, Rodriguez J, Panizo A, Gil B, Inarrairaegui M, Herrero I, Quiroga J, Prieto J. Int J Radiat Oncol Biol Phys; 2006 Nov 01; 66(3):792-800. PubMed ID: 16904840 [Abstract] [Full Text] [Related]
25. Cholecystoduodenal fistula after yttrium-90 radioembolization. Patel NM, Yuan J, David J. J Clin Gastroenterol; 2010 Sep 01; 44(8):594-5. PubMed ID: 20216427 [No Abstract] [Full Text] [Related]
26. Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres. Kwok PC, Leung KC, Cheung MT, Lam TW, Szeto LT, Chou SQ, Chia NH, Tong CM, Yuen PK, Cheung CH, Law CK. J Gastroenterol Hepatol; 2014 Nov 01; 29(11):1897-904. PubMed ID: 24734957 [Abstract] [Full Text] [Related]
27. State of the art: radiolabeled microspheres treatment for liver malignancies. Deleporte A, Flamen P, Hendlisz A. Expert Opin Pharmacother; 2010 Mar 01; 11(4):579-86. PubMed ID: 20163269 [Abstract] [Full Text] [Related]
33. [Radioembolization with 32P-labelled glass microspheres for advanced hepatocellular carcinoma]. Yan L, Li L, Chen S. Zhonghua Wai Ke Za Zhi; 1996 Sep 01; 34(9):526-9. PubMed ID: 9594154 [Abstract] [Full Text] [Related]